Case Report
Copyright ©The Author(s) 2022.
World J Clin Cases. Jun 26, 2022; 10(18): 6307-6313
Published online Jun 26, 2022. doi: 10.12998/wjcc.v10.i18.6307
Table 1 Comparison of the features of 41 cases with metastatic and non-metastatic thyroid-like follicular carcinoma of the kidney reported from 2006 to 2022
Features
Non-metastatic (n = 34)
Metastatic (n = 7)
Age (yr), mean ± SD (range)41.7 ± 17 (10-83) 42.6 ± 14 (27-68)
Female sex 18/33 (55%; 1 unknown) 4/7 (57%)
Clinical presentation
Incidental24 (71%)4 (57%)
Flank pain/haematuria 10 (29%)3 (43%)
History of malignancy (other sites) 8 (24%)1 (14%)
Tumour characteristics
Size (cm), mean ± SD (range)4.2 ± 2.3 (1.1-11.8) 5.3 ± 2.3 (3.5-10)
Right/left sided17/16 (1 unknown)5 2
Necrosis 9 (24%)3 (43%)
Ki-67 proliferation index1% to 30% (n = 6) 6% (n = 1)
pT stage
1a203
1b103
2a10
2b20
Immunohistochemical features
CK724/25 (96%)5/6 (83%)
CK203/14 (21%)2/4 (50%)
CD104/23 (17%)1/5 (20%)
Vimentin20/25 (80%)3/4 (75%)
PAX8 10/11 (91%)3/4 (75%)
Site of metastasis-Bone (2), lung (3), lymph node (2)
Follow-up period (mo)22.1 ± 19.8 30.6 ± 28.8
Disease/death at follow-up02 (28%)